Indeed, SIRT1/DNMT3B complex was verified after 24h of anchorage blockade and at late stages of melanoma progression, but not at the pre-malignant 4C cells, a result that we aforementioned for SIRT1/Mxd1 interaction. Here, DNMT3B is linked to melanoma.